Average Co-Inventor Count = 6.37
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Abbott Laboratories Corporation (19 from 4,179 patents)
2. Abbvie Inc. (4 from 822 patents)
3. Other (1 from 832,880 patents)
4. Abbvie Bahamas Limited (6 patents)
24 patents:
1. 9623009 - Veliparib in combination with carboplatin and paclitaxel for the treatment of non-small cell lung cancer in smokers
2. 9283222 - Inhibitors of poly(ADP-ribose)polymerase
3. 8697736 - 1H-benzimidazole-4-carboxamides substituted with phenyl at the 2-position are potent PARP inhibitors
4. 8546368 - Pyrazoloquinolones are potent PARP inhibitors
5. 8466150 - Inhibitors of poly(ADP-ribose)polymerase
6. 8217070 - 2-substituted-1H-benzimidazole-4-carboxamides are PARP inhibitors
7. 8183250 - Potent PARP inhibitors
8. 8148384 - Substituted thieno[3,2-d]pyrimidine PIM kinase inhibitors as cancer chemotherapeutics
9. 8143284 - Poly(ADP-ribose)polymerase inhibitors
10. 8067613 - Benzimidazole poly(ADP ribose)polymerase inhibitors
11. 7999117 - Substituted 1H-benzimidazole-4-carboxamides are potent PARP inhibitors
12. 7956185 - Cyclobut-3-ene-1,2,-dione inhibitors of polo-like kinases
13. 7790721 - Pyrroloquinoxalinone inhibitors of poly(ADP-ribose)polymerase
14. 7728026 - 2-substituted-1 h-benzimidazile-4-carboxamides are PARP inhibitors
15. 7595406 - Substituted 1H-benzimidazole-4-carboxamides are potent PARP inhibitors